HGS’ Lupus Candidate Demonstrates Efficacy In Three-Year Continuation Study
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech continues to aim for a 2010 BLA for LymphoStat-B, with Phase III data expected next year.
You may also be interested in...
Emerging Phase III Data Validate Clinical Trial Design In Lupus
Over a span of little more than a month this summer, the face of clinical trials for lupus drugs changed considerably for the better.
Emerging Phase III Data Validate Clinical Trial Design In Lupus
Over a span of little more than a month this summer, the face of clinical trials for lupus drugs changed considerably for the better.
GSK's Option Strategy For Human Genome Sciences' Lupus Drug Looking Smarter After BLISS-52 Win
Positive data from one of two Phase III trials needed for a BLA raise hopes, stock prices for the two companies.